Liver Disease Management

Nutritional Support

The European Society for Clinical Nutrition and Metabolism (ESPEN) guidelines recommend standard enteral formulas for patients with liver disease, stating that specialized liver formulas have no proven benefits 1
Nutritional therapy for patients with severe alcoholic hepatitis should focus on meeting caloric and protein requirements through standard nutrition rather than specialized liver supplements, according to ESPEN guidelines 2, 3
Standard enteral formulas are recommended for patients with acute liver failure, as there is no evidence that specialized formulas with branched-chain amino acids improve outcomes, as stated by ESPEN guidelines 2, 3
For patients with liver failure who cannot eat orally, the recommended approach is standard enteral nutrition via nasogastric/nasojejunal tube rather than specialized liver supplements 3, 4

N-acetylcysteine is the only liver-supportive agent with strong evidence, but only for acetaminophen-induced acute liver failure 5
For non-acetaminophen acute liver failure, N-acetylcysteine should only be used in clinical trial settings 5
Extracorporeal liver support systems have shown no clear effect on mortality in multiple systematic reviews and should only be used within clinical trials 5, 6

Seven randomized controlled trials involving 415 patients with acute liver failure showed no significant improvement in survival with artificial liver support systems 6